Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
Open Access
- 26 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Pulmonary Medicine
- Vol. 10 (1), 45
- https://doi.org/10.1186/1471-2466-10-45
Abstract
Pneumonia, and particularly nosocomial (NP) and ventilator-associated pneumonias (VAP), results in high morbidity and costs. NPs in particular are likely to be caused by Pseudomonas aeruginosa (PA), ~20% of which in observational studies are resistant to imipenem. We sought to identify the burden of PA imipenem resistance in pneumonia.Keywords
This publication has 73 references indexed in Scilit:
- Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005Emerging Infectious Diseases, 2008
- Hospitalizations and Deaths Caused by Methicillin-ResistantStaphylococcus aureus, United States, 1999–2005Emerging Infectious Diseases, 2007
- Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center ExperienceAntimicrobial Agents and Chemotherapy, 2007
- Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled TrialAntimicrobial Agents and Chemotherapy, 2007
- Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)Diagnostic Microbiology and Infectious Disease, 2002
- Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)Diagnostic Microbiology and Infectious Disease, 1998
- A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patientsInfection, 1995
- Treatment of Severe Pneumonia in Hospitalised PatientsDrugs, 1995
- Comparison of Ciprofloxacin with Imipenem in the Treatment of Severe Pneumonia in Hospitalised Geriatric PatientsDrugs, 1995
- Interventional antimicrobial therapy in febrile neutropenic patientsAnnals of Hematology, 1994